ANALYSIS OF ANTIBODIES AGAINST EPSTEIN-BARR VIRUS AND VIRAL DNA QUANTIFICATION AS EARLY SCREENING TOOLS OF NASOPHARYNGEAL CARCINOMA

被引:0
|
作者
Hutajulu, S. H. [1 ]
Hariwiyanto, B. [1 ]
Herdini, C. [1 ]
Nugraheni, A. P. [1 ]
Gunarti, H. [1 ]
Harijadi, A. [1 ]
Mubarika, S. [1 ]
Indrasari, S. R. [1 ]
Middeldorp, J. M. [2 ]
机构
[1] Univ Gadjah Mada, Fac Med, Yogyakarta, Indonesia
[2] VU Univ Med Ctr, Dept Pathol, Amsterdam, Netherlands
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:323 / 323
页数:1
相关论文
共 50 条
  • [31] Epstein-Barr Virus MicroRNAs in Nasopharyngeal Carcinoma
    Tsiambas, Evangelos
    Mastronikolis, Nicholas S.
    Fotiades, Panagiotis P.
    Ragos, Vasileios
    Kavantzas, Nikolaos
    Lazaris, Andreas C.
    PATHOLOGY & ONCOLOGY RESEARCH, 2020, 26 (02) : 1347 - 1348
  • [32] The role of Epstein-Barr virus in nasopharyngeal carcinoma
    Su, Zhi Yi
    Siak, Pui Yan
    Leong, Chee-Onn
    Cheah, Shiau-Chuen
    FRONTIERS IN MICROBIOLOGY, 2023, 14
  • [33] Epstein-Barr virus infection and nasopharyngeal carcinoma
    Tsao, Sai Wah
    Tsang, Chi Man
    Lo, Kwok Wai
    PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2017, 372 (1732)
  • [34] FURTHER STUDIES ON ANTIBODIES TO EARLY ANTIGENS INDUCED BY EPSTEIN-BARR VIRUS IN NASOPHARYNGEAL CARCINOMA PATIENTS
    IDA, S
    HINUMA, Y
    CHU, CT
    CHIOU, JF
    LAI, JG
    YANG, CS
    LYNN, TC
    HSU, MM
    TU, SM
    KAWAMURA, A
    GANN, 1973, 64 (06): : 545 - 553
  • [35] Specific IgA antibodies to recombinant early and nuclear antigens of Epstein-Barr virus in nasopharyngeal carcinoma
    Hsu, MM
    Hsu, WC
    Sheen, TS
    Kao, CL
    CLINICAL OTOLARYNGOLOGY, 2001, 26 (04): : 334 - 338
  • [36] ANTIBODIES TO EPSTEIN-BARR VIRUS CAPSID ANTIGEN AND EARLY ANTIGEN IN NASOPHARYNGEAL CARCINOMA AND COMPARISON GROUPS
    LIN, TM
    YANG, CS
    CHIOU, JF
    TU, SM
    CHEN, TY
    TU, YC
    LIN, PJ
    KAWAMURA, A
    HIRAYAMA, T
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1977, 106 (04) : 336 - 339
  • [37] Plasma Epstein-Barr virus (EBV) DNA: Role as a screening test for nasopharyngeal carcinoma (NPC)?
    Wong, LP
    Lai, KTW
    Tsui, E
    Kwong, KH
    Tsang, RHN
    Ma, ESK
    INTERNATIONAL JOURNAL OF CANCER, 2005, 117 (03) : 515 - 516
  • [38] Screening for nasopharyngeal carcinoma using plasma Epstein-Barr virus DNA: Technological and clinical insights
    Lo, Yuk Ming Dennis
    CANCER RESEARCH, 2019, 79 (13)
  • [39] Clinical utility of circulating Epstein-Barr virus DNA analysis for the management of nasopharyngeal carcinoma
    Fung, Sherwood Y. H.
    Lam, Jacky W. K.
    Chan, Kwan Chee Allen
    CHINESE CLINICAL ONCOLOGY, 2016, 5 (02)
  • [40] Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulating Epstein-Barr virus DNA
    Lo, YMD
    Chan, ATC
    Chan, LYS
    Leung, SF
    Lam, CW
    Huang, DP
    Johnson, PJ
    CANCER RESEARCH, 2000, 60 (24) : 6878 - 6881